Product Information

PRAMIPEXOLE 0.25 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0472 per EA under NDC 57237018190. Its NADAC has been published 550 times since Feb 10, 2016.

FDA first approved this application on Oct 26, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PRAMIPEXOLE 0.25 MG TABLET

Pramipexole Dihydrochloride
$0.0472per EA

Strength

.25 mg/1

NDC

57237018190

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

PRAMIPEXOLE DIHYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA202633

FDA Approved

10/26/2012

TE Code

AB

On Market Since

10/26/2012

Pharmacological Classes

Dopamine Agonists
Nonergot Dopamine Agonist

Price Statistics

The NADAC for PRAMIPEXOLE 0.25 MG TABLET has been published 550 times since Feb 10, 2016, and over the history we have for it it has declined 28.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0472 per EA
All-time high$0.0676 (Mar 16, 2016)
All-time low$0.0364 (Nov 20, 2024)
52-week high$0.0473
52-week low$0.0456
Median price$0.0502
Average price$0.0509
Largest weekly change+24.4% (Jun 19, 2024)
Weeks tracked550
Tracking sinceFeb 10, 2016

Price History

1W

+0.7%

1M

+0.7%

3M

+0.5%

6M

+2.4%

1Y

+3.3%

3Y

-1.1%

5Y

-13.0%

All

-28.1%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of PRAMIPEXOLE 0.25 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PRAMIPEXOLE 0.25 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0472 per EA (NDC 57237018190), effective Aug 19, 2026.

How has the price of PRAMIPEXOLE 0.25 MG TABLET changed over time?

Over the history we have for it, the NADAC for PRAMIPEXOLE 0.25 MG TABLET has declined 28.1%. It has been tracked across 550 weekly CMS publications since Feb 10, 2016.

What are the highest and lowest recorded NADAC prices for PRAMIPEXOLE 0.25 MG TABLET?

Since Feb 10, 2016, the NADAC for PRAMIPEXOLE 0.25 MG TABLET has ranged from a low of $0.0364 (Nov 20, 2024) to a high of $0.0676 (Mar 16, 2016), with a median of $0.0502 per EA.

Are there cheaper alternatives to PRAMIPEXOLE 0.25 MG TABLET?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PRAMIPEXOLE 0.25 MG TABLET, is $0.0457 per EA — about 3% below PRAMIPEXOLE 0.25 MG TABLET.

Who manufactures PRAMIPEXOLE 0.25 MG TABLET?

PRAMIPEXOLE 0.25 MG TABLET (NDC 57237018190) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.